Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2 Pt 1
|
pubmed:dateCreated |
1997-4-24
|
pubmed:abstractText |
This study examined the effect of streptozotocin-induced diabetes on biliary reduced glutathione (GSH) efflux. Biliary GSH efflux was measured before and after acivicin, an irreversible inhibitor of gamma-glutamyl transpeptidase (GGT). One week after streptozotocin treatment, liver GGT activity doubled in diabetic rats but was inhibited by approximately 90% after acivicin to levels comparable to controls. Despite maximal GGT inhibition, biliary GSH efflux in untreated diabetic rats decreased progressively to approximately 10% of control levels by week 4 and was partially restored by insulin. The mechanism for the decrease in biliary GSH efflux was not increased paracellular permeability. GSH transport kinetics, ATP-stimulated taurocholate, and oxidized glutathione (GSSG) transport in canalicular liver plasma membrane prepared from diabetic and control rats were similar. Inhibition of protein kinase C (PKC) with high-dose H-7 increased biliary GSH efflux in diabetic animals to near control basal levels. In conclusion, streptozotocin-induced diabetic rats exhibit a progressive impairment in biliary GSH transport. One of the responsible mechanisms is heightened PKC tone in diabetic animals.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Glutathione,
http://linkedlifedata.com/resource/pubmed/chemical/Isoxazoles,
http://linkedlifedata.com/resource/pubmed/chemical/Protein Kinase C,
http://linkedlifedata.com/resource/pubmed/chemical/acivicin,
http://linkedlifedata.com/resource/pubmed/chemical/gamma-Glutamyltransferase
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0002-9513
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
272
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
G374-82
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9124363-Animals,
pubmed-meshheading:9124363-Bile,
pubmed-meshheading:9124363-Diabetes Mellitus, Experimental,
pubmed-meshheading:9124363-Disease Progression,
pubmed-meshheading:9124363-Enzyme Inhibitors,
pubmed-meshheading:9124363-Glutathione,
pubmed-meshheading:9124363-Isoxazoles,
pubmed-meshheading:9124363-Liver,
pubmed-meshheading:9124363-Male,
pubmed-meshheading:9124363-Perfusion,
pubmed-meshheading:9124363-Protein Kinase C,
pubmed-meshheading:9124363-Rats,
pubmed-meshheading:9124363-Rats, Sprague-Dawley,
pubmed-meshheading:9124363-gamma-Glutamyltransferase
|
pubmed:year |
1997
|
pubmed:articleTitle |
Progressive defect in biliary GSH secretion in streptozotocin-induced diabetic rats.
|
pubmed:affiliation |
Department of Medicine, University of Southern California School of Medicine, and the Department of Veteran Affairs Outpatient Clinic, Los Angeles 90033, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, Non-U.S. Gov't
|